Cargando…

Interaction of RAS Activation and Lipid Disorders Accelerates the Progression of Glomerulosclerosis

Background: The activation of the renin-angiotensin system (RAS) and lipid disorders are major risk factors in progressive chronic kidney disease. This study aimed to investigate the potential synergistic mechanisms of RAS activation and lipid disorders that contribute to glomerulosclerosis. Materia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Kun-Ling, Ni, Jie, Wang, Chang-Xian, Liu, Jing, Zhang, Yang, Wu, Yu, Lv, Lin-Li, Ruan, Xiong-Zhong, Liu, Bi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804787/ https://www.ncbi.nlm.nih.gov/pubmed/24151433 http://dx.doi.org/10.7150/ijms.6635

Ejemplares similares

Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury
por: Zhang, Yang, et al.
Publicado: (2016)

Inflammatory Stress Exacerbates the Progression of Cardiac Fibrosis in High-Fat-Fed Apolipoprotein E Knockout Mice via Endothelial-Mesenchymal Transition
por: Ma, Kun Ling, et al.
Publicado: (2013)

Inflammation Disrupts the LDL Receptor Pathway and Accelerates the Progression of Vascular Calcification in ESRD Patients
por: Liu, Jing, et al.
Publicado: (2012)

Correction: Inflammation Disrupts the LDL Receptor Pathway and Accelerates the Progression of Vascular Calcification in ESRD Patients
por: Liu, Jing, et al.
Publicado: (2013)

Role of Podocyte Injury in Glomerulosclerosis
por: Lu, Chen-Chen, et al.
Publicado: (2019)

Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis
por: Angeletti, Andrea, et al.
Publicado: (2020)

Exploring the mechanisms of renoprotection against progressive glomerulosclerosis
por: OITE, Takashi
Publicado: (2011)

217 Is it Idiopathic Nodular Glomerulosclerosis or Diabetic Glomerulosclerosis?
Publicado: (2022)

Increased mTORC1 activity contributes to atherosclerosis in apolipoprotein E knockout mice and in vascular smooth muscle cells()
por: Ma, Kun Ling, et al.
Publicado: (2013)

Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells
por: Ni, Jie, et al.
Publicado: (2013)

Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis
por: Kim, Jae Seok, et al.
Publicado: (2016)

Lipid Profiles of RAS Nanoclusters Regulate RAS Function
por: Zhou, Yong, et al.
Publicado: (2021)

Global Glomerulosclerosis and Segmental Glomerulosclerosis Could Serve as Effective Markers for Prognosis and Treatment of IgA Vasculitis With Nephritis
por: Tan, Jiaxing, et al.
Publicado: (2020)

Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
por: Umstead, MaKendra, et al.
Publicado: (2017)

Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models
por: Yang, Ru-chun, et al.
Publicado: (2018)

Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007)

Pathophysiology of focal segmental glomerulosclerosis
por: Reidy, Kimberly, et al.
Publicado: (2007)

INSULIN-INDUCED GLOMERULOSCLEROSIS IN THE RABBIT
por: Mohos, Steven C., et al.
Publicado: (1963)

Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016)

Unwinding focal segmental glomerulosclerosis
por: Peev, Vasil, et al.
Publicado: (2017)

Current Trends on Glomerulosclerosis Regression
por: Stoian, Marilena, et al.
Publicado: (2020)

REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors
por: Qiao, Shuxi, et al.
Publicado: (2020)

Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference
por: Mathew, Elza Neelima, et al.
Publicado: (2020)

Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
por: Zhuang, Qiyuan, et al.
Publicado: (2020)

Regulation of Ras Exchange Factors and Cellular Localization of Ras Activation by Lipid Messengers in T Cells
por: Jun, Jesse E., et al.
Publicado: (2013)

Balance between the two kinin receptors in the progression of experimental focal and segmental glomerulosclerosis in mice
por: Pereira, Rafael Luiz, et al.
Publicado: (2014)

IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis
por: Pačić, Arijana, et al.
Publicado: (2017)

Actinic Granuloma with Focal Segmental Glomerulosclerosis
por: Phasukthaworn, Ruedee, et al.
Publicado: (2016)

Alendronate-associated focal segmental glomerulosclerosis
por: Prikis, Marios, et al.
Publicado: (2009)

Interferon Induced Focal Segmental Glomerulosclerosis
por: Kayar, Yusuf, et al.
Publicado: (2016)

Focal Segmental Glomerulosclerosis in Waldenström's Macroglobulinemia
por: Batra, Akshee, et al.
Publicado: (2020)

Idiopathic nodular glomerulosclerosis and differential diagnosis
por: Solares, Sergio Raúl Alvizures, et al.
Publicado: (2020)

Non-diabetic metabolic nodular glomerulosclerosis
por: Mateus, Catarina, et al.
Publicado: (2022)

Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models
por: Chen, Jin-Shuen, et al.
Publicado: (2016)

Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report
por: Liu, Lin, et al.
Publicado: (2021)

Activation of Src Mediates PDGF-Induced Smad1 Phosphorylation and Contributes to the Progression of Glomerulosclerosis in Glomerulonephritis
por: Mima, Akira, et al.
Publicado: (2011)

A CF patient with progressive proteinuric renal disease: a CF-specific nodular glomerulosclerosis?
por: O’Connell, Oisin, et al.
Publicado: (2010)

Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat
por: Wang-Rosenke, Yingrui, et al.
Publicado: (2013)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Erratum to: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models
por: Chen, Jin-Shuen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_otep7ig31l95blvggvvqm8l02s